Whilst we show no adverse effects of pancreatic fat on β-cell function in this cohort of women who were overweight or obese but did not have T2DM, we consider that there may be some salient effects on first-phase insulin response in early stages of dysglycaemia that warrant further investigation. The gene discussed is INS; the disease is type 2 diabetes mellitus.